Prescient Therapeutics LimitedASX: PTX

FDA grants broader orphan drug status to PTX100 for TCLs

Mar 9, 2023 at 3:35 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment